The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins

Thrombosis and Haemostasis

Volumn 76, Issue 2, 1996, Pages 205-207

  Geng, Jie Ping ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CARBOXYL GROUP; GLUTAMIC ACID DERIVATIVE; MUTANT PROTEIN; PROTEIN C; VITAMIN K GROUP;

AMINO ACID SEQUENCE; ARTICLE; CARBOXYLATION; CHIMERA; CONTROLLED STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0029841825     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650555     Document Type: Article

References (24)

1. Bancroft JD, McDowell SA, Friezner-Degen SJ. The human prothrombin gene: Transcriptional regulation in HepG2 cells. Biochemistry 1992; 31: 12469-76.
2. O'Hara PJ, Grant FJ, Haldeman BA, Gray, CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158-62.
3. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
4. Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human factor X: A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 1986; 25: 5098-102.
5. Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-7.
6. Schmidel DK, Tatro AV, Phelps AG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-52.
7. Rabiet M-J, Jorgensen MJ, Furie B, Furie BC. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that β-hydroxylation and γ-carboxylation are independent events. J Biol Chem 1987; 262: 14895-8.
8. Foster DC, Rudinski MS, Schach BG, Berkner KL, Kumar AA, Hagen FS, Sprecher CA, Insley MY, Davie EW. Propeptide of human protein C is necessary for γ-carboxylation. Biochemistry 1987; 26: 7003-11.
9. Jorgensen MJ, Cantor AB, Furie BC, Brown CL, Shoemaker CB, Furie B. Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX. Cell 1987; 48: 185-91.
10. Huber P, Schmitz T, Griffin J, Jacobs M, Walsh C, Furie B, Furie BC. Identification of amino acids in the γ-carboxylation recognition site of the propeptide of prothrombin. J Biol Chem 1990; 265; 12467-73.
11. Bristol JA, Furie BC, Furie B. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site. J Biol Chem 1993; 268: 7577-84.
12. Price PA, Fraser JD, Metz-Virca G. Molecular cloning of matrix gla protein: Implications for substrate recognition by the vitamin K-dependent γ-carboxylase. Proc Natl Acad Sci USA 1987; 84: 8335-9.
13. Zhang L, Castellino FJ. Role of the hexapeptide disulfide loop present in the γ-carboxyglutamic acid domain of protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C. Biochemistry 1991; 30: 6696-704.
14. Price PA, Williamson MK. Substrate recognition by the vitamin K-dependent γ-glutamyl carboxylase. Identification of a sequence homology between the carboxylase and the carboxylase recognition site in the substrate. Protein Sci 1993; 2: 1987-8.
15. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-34.
16. Foster DC, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984; 81: 4766-70.
17. Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci USA 1982; 79: 6461-4.
18. Yu S, Zhang L, Jhingan A, Christiansen WT, Castellino FJ. Construction, expression, and properties of a recombinant human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. Biochemistry 1994; 33: 823-31.
19. Christiansen WT, Castellino FJ. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX. Biochemistry 1994; 33: 5901-11.
20. Menhart N, Sehl LC, Kelley RF, Castellino FJ. Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with ω-amino acids. Biochemistry 1991; 30: 1948-57.
21. De Serrano VS, Menhart N, Castellino FJ. The expression, purification, and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator. Arch Biochem Biophys 1992; 294: 282-90.
22. 1-plasminogen by tissue plasminogen activator and retards fibrin polymerization. Int J Peptide Protein Res 1990; 35: 73-80.
23. Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80: 942-52.
24. Mullien P, Balland A, Lepage P, Mischler F, Dott K, Hauss C, Grandgeorge M, Lecocq J-P. Increased biological activity of a recombinant factor IX variant carrying alanine at position +1. Protein Eng 1990; 3: 629-33.